Dr. Catherine Sw Albin, MD

Dr. Albin practices at Grady Memorial Hospital in Atlanta, Georgia, part of The Fulton-DeKalb Hospital Authority.

Dr. Albin's NPI, 1043623119, was assigned on June 6, 2014. Dr. Albin graduated from Perelman School of Med at the University of Pennsylvania in 2014. Dr. Albin holds Georgia license 86575.

Dr. Albin's primary practice is Grady Memorial Hospital, at 80 Jesse Hill, Jr Drive SE, Atlanta, GA 30303 in Fulton County. The practice phone is (404) 616-1000.

Dr. Albin's primary practice is Grady Memorial Hospital in Atlanta, Georgia, part of The Fulton-DeKalb Hospital Authority. Dr. Albin is also affiliated with Emory University Hospital. The medical group on file is Emory Clinic. Dmand AI also links Dr. Albin to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Albin practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Albin's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Albin is licensed in Georgia.

CMS data shows 29 Medicare services from Dr. Albin across 1 procedure code in 2024, for 27 Medicare patients. Medicare paid $4,617 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 27 Medicare patients who saw Dr. Albin in 2024. The largest group is 65 to 74, with 11 patients. 75% of them have high blood pressure, and 75% have stroke or tia. Their average risk score is 2.84, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Albin's median patient age at 70, with 57% women.

In 2024, Dr. Albin wrote 50 Medicare Part D claims for 18 patients. 90% of them were for generic drugs. CMS names the drug for 16 of them, across 1 drug with 11 or more claims each, at $63 in total drug cost. In 2018, CMS named 20 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Albin for performance year 2024, reported through an alternative payment model (APM). Dr. Albin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 19 papers to Dr. Albin, published from 2021 to 2025. 2023 was the busiest year, with 7. The most frequent topics are Critical Care and Neurology. Dr. Albin has published most often in Neurol Educ. Dr. Albin's most frequent co-authors are Aaron Lee Berkowitz, MD, PhD, Neha S. Dangayach, MD and Marc-Alain Babi, MD.

CMS Open Payments shows 4 general payments to Dr. Albin from 3 drug and device companies from 2022 to 2024. Grants make up the largest share, 83% of the total. Biogen, Inc. paid the most, $8,000.

Dr. Albin graduated from Perelman School of Med at the University of Pennsylvania in 2014.